ClearPoint Neuro (CLPT) Amortization of Deferred Charges (2011 - 2026)

ClearPoint Neuro has disclosed Amortization of Deferred Charges across 15 years of filings, most recently posting $525000.0 for Q1 2026.

• Amortization of Deferred Charges for Q1 2026 came in at $525000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $608000.0 (up 4153.33% YoY), and the FY2025 annual result was $83000.0, changed N/A from the prior year.
• Amortization of Deferred Charges came in at $525000.0 for Q1 2026 at ClearPoint Neuro, up from -$407000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $525000.0 in Q1 2026 to a low of -$407000.0 in Q4 2025.
• The 5-year median for Amortization of Deferred Charges is $14000.0 (2022), against an average of $45000.0.
• Peak annual rise in Amortization of Deferred Charges reached 819.61% in 2025, while the deepest fall reached 698.04% in 2025.
• ClearPoint Neuro's Amortization of Deferred Charges stood at $14000.0 in 2022, then climbed by 7.14% to $15000.0 in 2023, then slumped by 440.0% to -$51000.0 in 2024, then slumped by 698.04% to -$407000.0 in 2025, then surged by 228.99% to $525000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $525000.0 (Q1 2026), -$407000.0 (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.